Form 4: HCI Group CEO Paresh Patel Receives 200,000 Restricted Stock Grant
SEC Form 4 Filing
HCI Group's CEO, Paresh Patel, reports the acquisition of 200,000 shares of restricted stock and provides updates on existing stock options and restricted stock grants.
Summary
- Paresh Patel, CEO of HCI Group, filed a Form 4 detailing changes in beneficial ownership.
- The filing reports the acquisition of 200,000 shares of common stock through a restricted stock grant effective April 17, 2024.
- The restricted shares will vest in installments if the fair market value of HCI Group's stock equals or exceeds $200 for 30 consecutive trading days, with vesting dates starting March 15, 2025.
- Any unvested shares will be forfeited six years and one day after the grant date.
- The filing also updates the status of previously granted stock options with exercise prices ranging from $40 to $70 and expiration dates between 2027 and 2033.
- Additionally, the filing mentions a previous restricted stock grant of 10,000 shares from February 26, 2021, which will vest if the stock price reaches $140 for 30 consecutive days.
Sentiment
Score: 7
Explanation: The document is neutral to slightly positive. The stock grant indicates confidence in the company's future, but the vesting conditions are challenging.
Positives
- The restricted stock grant aligns the CEO's interests with those of shareholders, incentivizing him to increase the company's stock value.
- The vesting conditions based on stock price performance suggest confidence in the company's future prospects.
- The CEO's existing stock options represent a significant potential ownership stake in the company.
Negatives
- The vesting of the restricted stock is contingent on a significant increase in the stock price to $200, which may not occur.
- Unvested shares will be forfeited after six years, potentially limiting the long-term incentive effect.
Risks
- The company's stock price may not reach the $200 threshold required for the restricted shares to vest.
- Changes in market conditions or company performance could impact the value of the CEO's stock options.
- The forfeiture of unvested shares could reduce the CEO's incentive to focus on long-term value creation.
Future Outlook
The vesting of the restricted stock is dependent on the company's stock price reaching certain targets, indicating a focus on future growth and value creation.
Industry Context
Stock grants and options are common forms of executive compensation in publicly traded companies, particularly in the insurance industry, to align management's interests with those of shareholders.
Comparison to Industry Standards
- Executive compensation packages in the insurance industry often include a mix of salary, bonus, stock options, and restricted stock.
- The size and vesting conditions of stock grants can vary significantly depending on the company's size, performance, and industry benchmarks.
- Comparing HCI Group's executive compensation practices to those of its peers, such as Heritage Insurance Holdings or United Insurance Holdings, would provide a more comprehensive assessment.
Stakeholder Impact
- Shareholders may view the stock grant positively as it aligns management's interests with theirs.
- Employees may be motivated by the potential for increased company value and stock price appreciation.
Key Dates
| Date | Description |
|---|---|
| 02/26/2021 | Date of original restricted stock grant of 10,000 shares. |
| 01/07/2017 | Date the options were granted at an exercise price of $40.00 per share, in excess of the $39.71 market value. |
| 02/08/2018 | Date the options were granted at an exercise price of $40.00 per share, in excess of the $34.92 market value. |
| 01/15/2019 | Date the options were granted at an exercise price of $53.00 per share, in excess of the $47.94 market value. |
| 01/16/2020 | Date the options were granted at an exercise price of $48.00 per share, in excess of the $45.97 market value. |
| 09/15/2023 | Date the options were granted at an exercise price of $70.00 per share. |
| 12/14/2023 | Date the options vested. |
| 04/17/2024 | Effective date of the 200,000 restricted stock grant. |
| 03/15/2025 | First potential vesting date for 50,000 restricted shares. |
| 01/07/2027 | Expiration date of options granted on January 7, 2017. |
| 03/15/2026 | Second potential vesting date for 50,000 restricted shares. |
| 03/15/2027 | Third potential vesting date for 50,000 restricted shares. |
| 02/08/2028 | Expiration date of options granted on February 8, 2018. |
| 03/15/2028 | Fourth potential vesting date for 50,000 restricted shares. |
| 01/15/2029 | Expiration date of options granted on January 15, 2019. |
| 01/16/2030 | Expiration date of options granted on January 16, 2020. |
| 09/15/2033 | Expiration date of options granted on September 15, 2023. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.